Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia

被引：0
|
作者：
Singh, Reema [1 ]
Halder, Rohan [1 ]
Verma, Megha [1 ]
Mehta, Pallavi [1 ]
Agrawal, Narendra [1 ]
Ahmed, Rayaz [1 ]
Bhurani, Dinesh [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Hematooncol & BMT, New Delhi, India
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11713 / 11715
页数：3
相关论文
共 50 条
  • [31] Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax
    Bataller, Alex
    Bazinet, Alexandre
    Dinardo, Courtney D.
    Maiti, Abhishek
    Borthakur, Gautam
    Daver, Naval G.
    Short, Nicholas J.
    Jabbour, Elias J.
    Issa, Ghayas C.
    Pemmaraju, Naveen
    Yilmaz, Musa
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Loghavi, Sanam
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    BLOOD ADVANCES, 2024, 8 (04) : 927 - 935
  • [32] Impact of Race on Outcomes in Intermediate Risk Acute Myeloid Leukemia
    Abraham, Ivy
    Patel, Anand Ashwin
    Zhang, Yanyu
    Liu, Li C.
    Frankfurt, Olga
    Khan, Irum
    BLOOD, 2018, 132
  • [33] Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia
    Ball, Somedeb
    Jain, Akriti G.
    Al Ali, Najla
    Hayden, Alexander
    Swoboda, David M.
    Aguirre, Luis E.
    Sallman, David A.
    Padron, Eric
    Sweet, Kendra
    Lancet, Jeffrey E.
    Watts, Justin
    Pollyea, Daniel A.
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S293 - S293
  • [34] Hypomethylating Agent and Venetoclax Combination Therapy Yields Superior Outcomes When Compared to Hypomethylating Agent Monotherapy in Patients ≥70 Years with Acute Myeloid Leukemia
    Zhang, Yumeng
    Asghari, Hannah H.
    Chan, Onyee
    Lee, Dasom
    Extermann, Martine
    Al Ali, Najla
    Deutsch, Yehuda E.
    Padron, Eric
    Kuykendall, Andrew T.
    List, Alan F.
    Fernandez, Hugo F.
    Lancet, Jeffrey E.
    Komrokji, Rami S.
    Sallman, David A.
    Talati, Chetasi
    Sweet, Kendra L.
    BLOOD, 2019, 134
  • [35] LENALIDOMIDE MAINTENANCE IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKEMIA
    Kadia, T.
    Cortes, J.
    Ravandi, F.
    Daver, N.
    Jabbour, E.
    Ferrajoli, A.
    Pemmaraju, N.
    Naqvi, K.
    Pelletier, S.
    Brandt, M.
    Estrov, Z.
    Kantarjian, H.
    HAEMATOLOGICA, 2017, 102 : 383 - 384
  • [36] Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia
    Jiang, Hao
    Liu, Xiao-Hong
    Kong, Jun
    Wang, Jing
    Jia, Jin-Song
    Lu, Sheng-Ye
    Gong, Li-Zhong
    Zhao, Xiao-Su
    Jiang, Qian
    Chang, Ying-Jun
    Wang, Yu
    Ruan, Guo-Rui
    Qin, Ya-Zhen
    Liu, Kai-Yan
    Huang, Xiao-Jun
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2949 - 2956
  • [37] Fusion Transcript Reduction in Core Binding Factor Acute Myeloid Leukemia: Maintenance Strategy with Hypomethylating Agents
    Ragon, Brittany Knick
    Daver, Naval
    Garcia-Manero, Guillermo
    Ohanian, Maro
    Ferrajoli, Alessandra
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2015, 126 (23)
  • [38] Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
    Gabellier, Ludovic
    Peterlin, Pierre
    Thepot, Sylvain
    Hicheri, Yosr
    Paul, Franciane
    Gallego-Hernanz, Maria Pilar
    Bertoli, Sarah
    Turlure, Pascal
    Pigneux, Arnaud
    Guieze, Romain
    Ochmann, Marlene
    Malfuson, Jean-Valere
    Cluzeau, Thomas
    Thomas, Xavier
    Tavernier, Emmanuelle
    Jourdan, Eric
    Bonnet, Sarah
    Tudesq, Jean-Jacques
    Raffoux, Emmanuel
    ANNALS OF HEMATOLOGY, 2024, 103 (03) : 759 - 769
  • [39] Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
    Gangat, Naseema
    Ilyas, Rimal
    Johnson, Isla M.
    McCullough, Kristen
    Al-Kali, Aref
    Alkhateeb, Hassan B.
    Begna, Kebede H.
    Mangaonkar, Abhishek
    Litzow, Mark R.
    Hogan, William
    Shah, Mithun
    Patnaik, Mrinal M.
    Pardanani, Animesh
    Tefferi, Ayalew
    HAEMATOLOGICA, 2023, 108 (11) : 3170 - 3174
  • [40] Outcome of Elderly Patients with Acute Myeloid Leukemia (AML) Post Hypomethylating Agent (HMA) Failure.
    Takahashi, Koichi
    Kantarjian, Hagop M.
    Ghanem, Hady
    Ravandi, Farhad
    Cortes, Jorge E.
    Kadia, Tapan M.
    O'Brien, Susan
    Pierce, Sherry A.
    Jain, Nitin
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    BLOOD, 2012, 120 (21)
12345